Serum antioxidant activity (ADA) was correlated with the serum caeruloplasmin and serum copper concentration and with the total and available serum iron-binding capacity in 313 normal and abnormal subjects. In all groups except in patients with Wilson's disease (hepatolenticular degeneration) there was a highly significant direct correlation between serum ADA and serum caeruloplasmin concentration. A statistically significant direct correlation between serum ADA and the available iron-binding capacity of serum was found only in normal subjects and in children with thalassaemia major and iron overload. There wall no correlation between serum ADA and the serum tocopherol concentration in any of the groups studied.
because of the known association between certain abnormal states and (a) an abnormally high or low serum caeruloplasmin or (b) an abnormally low iron-binding capacity. The 34 women taking oral contraceptives were either laboratory staff or women attending a family-planning clinic. All were taking preparations containing a combination of oestrogen and progesterone (Eugynon, Minovular, or Ouvranette) . The 40 pregnant women were attending the antenatal clinic at the City of London Maternity Hospital, London, and the Whittington Hospital, The groups of subjects studied are set out in Table 1 . The 120 normal controls were un selected hospital and laboratory staff, excluding women taking oral contraceptive tablets. (Because of the possibility of seasonal and other long-term variations the abnormal groups were compared to normal subgroups studied in parallel. In some tables and figures, therefore, the normal controls do not include all normal subjects.) The other groups were chosen Free-radical oxidation in general and the freeradical oxidation (peroxidation) of polyunsaturated lipids in particular is a potential threat to all organisms exposed to oxygen (Dormandy, 1969; 1971; Slater, 1972; Tappel, 1972) . The protective (antioxidant) mechanisms are complex, multifactorial, and differ from species to species (Dormandy, 1978) . In 1972, Vidlakova et al., showed that normal human serum behaved as a powerful antioxidant in some in vitro systems. This antioxidant activity (AOA) subsequently proved to be the function of two proteins (Stocks et al., 1974b) : one was the iron-free fraction of transferrin; the other was the coppercontaining protein, caeruloplasmin (AI-Timimi, 1977; Al-Timimi and Dormandy, 1977) . These findings suggested that in abnormal states associated with changes in the levels of these proteins the overall AOA might also be significantly raised or lowered. The present study was undertaken to test this possi bility. London. A subgroup of 14 were studied throughout their pregnancy. Patients with complicated pregnancies were excluded. The 75 patients with rheumatoid arthritis were attending the Department of Rheumatology, Whittington Hospital, London. All were on conventional anti-inflammatory/analgesic therapy only (daily dose ranges: ibuprofen, 50-100 mg; salicylates, 2-6 g; indomethacin, 1-2 g). Patients on penicillamine, gold, and hormone therapy were excluded. The clinical severity, duration, and activity of the disease varied widely. The 27 patients with thalassaemia major were attending the Paediatric Department, Whittington Hospital, London. All had been on a high-transfusion therapeutic regime (ie, regular transfusions of 2--4 units of blood at 6-8 weekly intervals) for periods ranging from nine months to 12 years. They were also receiving 3 g desferrioxamine per unit of blood. All were on folic acid supplements; and 18 were receiving ascorbic acid. Unless otherwise indicated, all data shown in the results are based on samples of blood obtained immediately before transfusion. In 17 of the 27 patients these results were compared to the findings in immediate post-transfusion blood. Five donor-blood samples were also analysed. Despite the iron-chelation treatment all patients showed clinical evidence of iron overload. The 17 patients with Wilson's disease (hepatolenticular degeneration) were under the care of the Medical Professorial Unit, Royal Free Hospital, London. They were members of 14 families and all but two were receiving n-penicillamine (average dose 1·6 g daily). At the time of study, five patients were asymptomatic, 10 showed biochemical and/or histological evidence of liver disease, and only two had neurological manifestations.
Methods
Because of some loss of linearity at high ADA (Fig. 1 ) the assay previously described for normal serum (Stocks et a1., 1974a; Al-Tirnirni and Dormandy, 1977) was slightly modified. Using 20~l instead of 50~1 serum and with an incubation time of 1 hour, precision was satisfactory (Table 2) . Thiobarbituric-acid (TBA) reactivity was expressed as % inhibition of 'malonyldialdehyde' (MDA) generation as described previously (Al-Timimi and Dormandy, 1977) . Serum caeruloplasmin and transferrin were measured by single radial immunodiffusion (Mancini et a1., 1965) using M-Partigen plates and standards obtained from Hoechst Pharmaceuticals (Hounslow, Middx, UK). Serum iron and total iron-binding capacity were measured as described by Young and Hicks (1965) . The available iron-binding capacity was calculated. Serum copper was measured by atomic absorption spectroscopy using a Perkin-Elmer atomic absorption spectroscope model 306 (Perkin-Elmer, Beaconsfield, Bucks, UK) as described by Scudder et a1., (1978) . Serum tocopherol was measured by the automated colorimetric method of Gutteridge and Stocks (1976) .
Results
Although serum ADA in normal men and women aged 23-62 years fell within a comparatively narrow range it did not clearly conform, to a normal distribution (Fig. 2) . Non-parametric as well as parametric statistical methods were therefore used.
Diurnal and daily variations were small « 3 %and < 5 % respectively). Variations over a four-month period in a normal subject are illustrated in Figure 3 . The mean, range, and standard deviation of serum ADA and related variables in the different groups are set out in Table 3 . The significances of differences between the groups are shown in Table 4 main correlations in Table 5 . Serum ADA was higher in normal women than in normal men and significantly raised in women taking contraceptive tablets ( Fig. 4 ). It rose progressively throughout pregnancy (Fig. 5 ). Serum ADA was also significantly raised in both men and women with rheumatoid arthritis. In all these conditions the correlation (e) . and available iron-binding capacity (AIBC» (.( over a four-month period in a normal man. The points represent the means of three independent measurements on the same blood samples. between serum ADA and serum caeruloplasmin concentration was highly significant (Table 5 ; Fig. 5 ). The correlation between serum ADA and the available iron-binding capacity of serum was just significant in normal subjects but not in the other groups. There was no significant correlation between serum ADA and the serum iron or total transferrin concentration. Serum tocopherol concentration rose during pregnancy but did not significantly correlate with the rise in serum ADA. In thalassaemia, serum ADA correlated highly significantly with the serum caeruloplasmin concentration in both pre-transfusion and post-transfusion blood, both variables rising after transfusion (Table 6 ). In this condition serum ADA also correlated with both the serum iron concentration (inversely) and the available iron-binding capacity of serum (directly) (Figs 6 and 7) ; but partial regression analysis showed that the serum caeruloplasmin concentration was five times more powerful a determinant than the available iron-binding capacity and 10 times more powerful than the serum iron concentration. Serum tocopherol concentration was significantly lower in thalassaemics than in normal children but it did not correlate with serum ADA. In Wilson's disease (hepatolenticular degeneration) both serum ADA and the serum caeruloplasmin 
Discussion
The results clearly establish that serum ADA is largely a function of the serum caeruloplasmin concentration not only in normal blood but also in a wide range of abnormal states. The correlation between serum ADA and the available iron-binding capacity is less strong: in our series it was statistically significant only in normal subjects and in thalassaemic patients. The apparent non-contribution of tocopherol, still the best-known of biological antioxidants, must be subject to two reservations. Firstly, none of the subjects in the present series had an abnormally low serum vitamin E (as seen in severe fat malabsorption or in abetalipoproteinaemia). Secondly, none was receiving large (pharmacological) doses of the vitamin. In normal subjects, such doses can raise the serum level to well above the range recorded in the present study. The vitamin then becomes a significant contributor to ADA (Dormandy, 1977) .
Caeruloplasmin is one of the acute-phase-reacting proteins, the possible 'useful' role of which in the systemic inflammatory response has long remained speculative (Rice, 1961; Crockson et al., 1966; Frieden and Hsieh, 1976) . It may prove to be related to its powerful antioxidant property. Strong circumstantial evidence now suggests that a reciprocal relationship exists between tissue damage and freeradical activity. There is no doubt that free-radical activity-lipid peroxidation in particular-can irreversibly damage cells (Slater, 1972) . But there is also evidence that cell damage itself, the trigger mechanism of inflammation, favours and facilitates the generation of free radicals (Dormandy, 1979) . The possible biological importance of serum AOA (and therefore of caeruloplasmin) is further underlined by recent evidence of the potency of lipid binding capacity was unfortunately not measured in these patients). In all groups the close correlation between serum caeruloplasmin and serum copper concentrations confirms earlier reports (Scudder et al., 1978) . concentration were extremely low. The inclusion of these patients therefore strongly reinforced the statistical significance of the correlation between the two variables in the series as a whole (Fig. 4) . However, the correlation within the group in isolation was not significant. (fJ-mole/1 1 Fig. 6 Serum ADA related to available iron-binding capacity in thalassaemic patients (pre-transfusion) (.) and a normal control series (0). Although the low serum AOA in Wilson's disease confirms the antioxidant effect of caeruloplasmin, caeruloplasmin deficiency in this condition is uniquely associated with the accumulation of copper complexes in the tissues. Since some of these complexes may have antioxidant properties, the disease cannot be regarded as a 'model' of low antioxidant peroxidation products in a wide range of in-vitro biological systems (Gutteridge, 1974; Dormandy, 1978; 1979) . The mechanism of the antioxidant action of caeruloplasmin is still uncertain though it may be 'paradoxically' related to its in-vitro oxidase-like activity (Osaki et al., 1966; Frieden and Hsieh, 1976; Dormandy, 1978) . In contrast to transferrin, which behaves as an antioxidant only when it is iron-free, caeruloplasmin is active only in combination with copper (Al-Tirnimi, 1977; AI-Timimi and Dorrnandy, 1978) .
Iron-eatalysed free-radical processes probably underlie many of the degenerative changes in chronic iron overload; and considerable circumstantial evidence points to a progressive decline in 'antioxidant status' in subjects maintained on a hightransfusion therapeutic regime (Modell, 1975) . It may be relevant to this that only in thalassaemia did the serum iron concentration significantly (and inversely) influence serum AOA. It may also account for the 'displacement' of the AOA caeruloplasmin regression line in this condition. There is no obvious explanation for the increase in both AOA and caeruloplasmin immediately after a blood transfusion (despite the low values in transfused blood). (Fig. 8) .
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